• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

宫颈上皮内瘤变III级患者中的人乳头瘤病毒特异性细胞毒性T淋巴细胞

Human papillomavirus-specific cytotoxic T lymphocytes in patients with cervical intraepithelial neoplasia grade III.

作者信息

Nimako M, Fiander A N, Wilkinson G W, Borysiewicz L K, Man S

机构信息

Department of Medicine, University of Wales College of Medicine, Cardiff, United Kingdom.

出版信息

Cancer Res. 1997 Nov 1;57(21):4855-61.

PMID:9354449
Abstract

Human papillomaviruses (HPVs), especially types 16 and 18, are strongly associated with the development of cervical intraepithelial neoplasia (CIN) and invasive carcinoma. The HPV E6 and E7 proteins are expressed constitutively in the majority of CIN lesions and carcinomas. Therefore, they are targets for the immune response against HPV and candidates for active immunotherapy. We have previously detected HPV-specific CTLs from the peripheral blood mononuclear cells from a cervical cancer patient following immunization with a recombinant vaccinia using in vitro restimulation with adenovirus recombinants expressing HPV16 or HPV18 E6/E7 fusion proteins. In this study, we used a similar protocol to determine the prevalence of CTL responses against HPV16 and HPV18 E6/E7 in the peripheral blood mononuclear cells from 10 CIN III and 10 normal subjects. HPV-specific CTL responses were detected in 6 of 10 CIN III subjects. These CTL lines recognized HPV16 E6/E7 proteins presented by at least three MHC class 1 HLA alleles and by HPV-transformed CaSki cells. No HPV-specific CTLs were detected in normal subjects. This study demonstrates the presence of naturally occurring HPV-specific memory CTLs in a majority of CIN III patients and provides an approach for further study of their role in modulating cervical malignancy.

摘要

人乳头瘤病毒(HPV),尤其是16型和18型,与宫颈上皮内瘤变(CIN)和浸润性癌的发生密切相关。HPV E6和E7蛋白在大多数CIN病变和癌组织中持续表达。因此,它们是针对HPV免疫反应的靶点以及主动免疫治疗的候选对象。我们之前通过用表达HPV16或HPV18 E6/E7融合蛋白的腺病毒重组体进行体外再刺激,从一名宫颈癌患者的外周血单个核细胞中检测到了HPV特异性CTL。在本研究中,我们采用类似方案来确定10名CIN III患者和10名正常受试者外周血单个核细胞中针对HPV16和HPV18 E6/E7的CTL反应的发生率。在10名CIN III受试者中有6名检测到了HPV特异性CTL反应。这些CTL系识别由至少三种MHC I类HLA等位基因以及HPV转化的CaSki细胞呈递的HPV16 E6/E7蛋白。在正常受试者中未检测到HPV特异性CTL。本研究证明了大多数CIN III患者中存在天然的HPV特异性记忆CTL,并为进一步研究它们在调节宫颈恶性肿瘤中的作用提供了一种方法。

相似文献

1
Human papillomavirus-specific cytotoxic T lymphocytes in patients with cervical intraepithelial neoplasia grade III.宫颈上皮内瘤变III级患者中的人乳头瘤病毒特异性细胞毒性T淋巴细胞
Cancer Res. 1997 Nov 1;57(21):4855-61.
2
Use of fluorogenic histocompatibility leukocyte antigen-A*0201/HPV 16 E7 peptide complexes to isolate rare human cytotoxic T-lymphocyte-recognizing endogenous human papillomavirus antigens.使用荧光组织相容性白细胞抗原-A*0201/人乳头瘤病毒16型E7肽复合物分离识别内源性人乳头瘤病毒抗原的罕见人类细胞毒性T淋巴细胞。
Cancer Res. 2000 Jan 15;60(2):365-71.
3
Vaccinia-expressed human papillomavirus 16 and 18 e6 and e7 as a therapeutic vaccination for vulval and vaginal intraepithelial neoplasia.痘苗病毒表达的人乳头瘤病毒16和18 E6和E7作为外阴和阴道上皮内瘤变的治疗性疫苗。
Clin Cancer Res. 2003 Nov 1;9(14):5205-13.
4
Infiltration of cervical cancer tissue with human papillomavirus-specific cytotoxic T-lymphocytes.人乳头瘤病毒特异性细胞毒性T淋巴细胞浸润宫颈癌组织。
Cancer Res. 1997 Jul 15;57(14):2943-50.
5
HPV16-specific cytotoxic T lymphocyte responses are detected in all HPV16-positive cervical cancer patients.在所有HPV16阳性的宫颈癌患者中均检测到HPV16特异性细胞毒性T淋巴细胞反应。
Gynecol Oncol. 2005 Jan;96(1):92-102. doi: 10.1016/j.ygyno.2004.08.052.
6
Identification of human papillomavirus 16-E6 protein-derived peptides with the potential to generate cytotoxic T-lymphocytes toward human leukocyte antigen-A24+ cervical cancer.鉴定具有产生针对人白细胞抗原 - A24 + 宫颈癌的细胞毒性T淋巴细胞潜力的人乳头瘤病毒16 - E6蛋白衍生肽。
Int J Oncol. 2005 Nov;27(5):1371-9.
7
Immunological and clinical responses in women with vulval intraepithelial neoplasia vaccinated with a vaccinia virus encoding human papillomavirus 16/18 oncoproteins.接种编码人乳头瘤病毒16/18癌蛋白的痘苗病毒的外阴上皮内瘤变女性的免疫和临床反应。
Cancer Res. 2003 Sep 15;63(18):6032-41.
8
Genetic immunization against cervical carcinoma: induction of cytotoxic T lymphocyte activity with a recombinant alphavirus vector expressing human papillomavirus type 16 E6 and E7.宫颈癌的基因免疫:用表达人乳头瘤病毒16型E6和E7的重组甲病毒载体诱导细胞毒性T淋巴细胞活性
Gene Ther. 2000 Nov;7(21):1859-66. doi: 10.1038/sj.gt.3301257.
9
Human CTL epitopes encoded by human papillomavirus type 16 E6 and E7 identified through in vivo and in vitro immunogenicity studies of HLA-A*0201-binding peptides.通过对HLA-A*0201结合肽的体内和体外免疫原性研究鉴定出的人乳头瘤病毒16型E6和E7编码的人CTL表位。
J Immunol. 1995 Jun 1;154(11):5934-43.
10
[Detection of high-risk human papillomavirus (HPV) E6 and E7 oncogene transcripts increases the specificity of the detection of a cervical intraepithelial neoplasia (CIN)].高危型人乳头瘤病毒(HPV)E6和E7癌基因转录物的检测提高了宫颈上皮内瘤变(CIN)检测的特异性。
Verh Dtsch Ges Pathol. 2005;89:195-200.

引用本文的文献

1
The immune microenvironment of cancer of the uterine cervix.宫颈癌的免疫微环境。
Histol Histopathol. 2024 Oct;39(10):1245-1271. doi: 10.14670/HH-18-727. Epub 2024 Mar 1.
2
Roles of B7-H3 in Cervical Cancer and Its Prognostic Value.B7-H3在宫颈癌中的作用及其预后价值。
J Cancer. 2018 Jun 23;9(15):2612-2624. doi: 10.7150/jca.24959. eCollection 2018.
3
Characterization of HPV18 E6-specific T cell responses and establishment of HPV18 E6-expressing tumor model.人乳头瘤病毒18型E6特异性T细胞反应的特征分析及人乳头瘤病毒18型E6表达肿瘤模型的建立。
Vaccine. 2017 Jul 5;35(31):3850-3858. doi: 10.1016/j.vaccine.2017.05.081. Epub 2017 Jun 7.
4
Mechanisms of virus immune evasion lead to development from chronic inflammation to cancer formation associated with human papillomavirus infection.病毒免疫逃逸机制导致与人类乳头瘤病毒感染相关的从慢性炎症发展到癌症形成。
Oncol Rev. 2012 Oct 5;6(2):e17. doi: 10.4081/oncol.2012.e17. eCollection 2012 Oct 2.
5
Immunotherapy of human papilloma virus induced disease.人乳头瘤病毒诱导疾病的免疫疗法。
Open Virol J. 2012;6:257-63. doi: 10.2174/1874357901206010257. Epub 2012 Dec 28.
6
A placebo-controlled randomized HPV16 synthetic long-peptide vaccination study in women with high-grade cervical squamous intraepithelial lesions.一项安慰剂对照随机 HPV16 合成长肽疫苗接种研究,对象为患有高级别宫颈鳞状上皮内病变的女性。
Cancer Immunol Immunother. 2012 Sep;61(9):1485-92. doi: 10.1007/s00262-012-1292-7. Epub 2012 Jun 9.
7
Safety and Immunogenicity of a Human Papillomavirus Peptide Vaccine (CIGB-228) in Women with High-Grade Cervical Intraepithelial Neoplasia: First-in-Human, Proof-of-Concept Trial.人乳头瘤病毒肽疫苗(CIGB-228)在高级别宫颈上皮内瘤变女性中的安全性和免疫原性:首例人体概念验证试验
ISRN Obstet Gynecol. 2011;2011:292951. doi: 10.5402/2011/292951. Epub 2011 Mar 24.
8
T lymphocytes derived from human cord blood provide effective antitumor immunotherapy against a human tumor.人脐血来源的 T 淋巴细胞对人肿瘤提供有效的抗肿瘤免疫治疗。
BMC Cancer. 2011 Jun 7;11:225. doi: 10.1186/1471-2407-11-225.
9
Immunosuppressive tumor microenvironment in cervical cancer patients.宫颈癌患者的免疫抑制性肿瘤微环境
Cancer Microenviron. 2011 Dec;4(3):361-75. doi: 10.1007/s12307-011-0066-7. Epub 2011 May 31.
10
Immunization with a poly (lactide co-glycolide) encapsulated plasmid DNA expressing antigenic regions of HPV 16 and 18 results in an increase in the precursor frequency of T cells that respond to epitopes from HPV 16, 18, 6 and 11.用聚(丙交酯-co-乙交酯)包裹的质粒 DNA 免疫,表达 HPV 16 和 18 的抗原区,导致对 HPV 16、18、6 和 11 表位有反应的 T 细胞前体频率增加。
Cell Immunol. 2011;270(1):62-9. doi: 10.1016/j.cellimm.2011.04.005. Epub 2011 Apr 23.